Prolactin role in the bovine uterus during adenomyosis
article
OA: closed
CC0
⤵ 15 in-corpus citations
AI-generated summary
This study investigates the role of prolactin in the bovine uterus, specifically examining its involvement in the development and progression of adenomyosis in cattle.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Adenomyosis is uterine dysfunction defined as the presence of endometrial glands within the myometrium. It is suggested that adenomyosis is estrogen-dependent pathology, and prolactin (PRL) also affects its development. In the uterus of ruminants, PRL stimulates gland proliferation and function. We hypothesized that in the bovine uterus, the expression of PRL and its receptors (PRLRs) during adenomyosis is disturbed and modulated by estradiol (E2). Uterine tissues were collected postmortem from cows; epithelial, stromal, and myometrial cells were isolated; and cultured and treated with E2. Material was divided into 2 groups: control (nonadenomyotic) and uteri with adenomyosis. In adenomyotic uterine tissue, PRL and its long-form receptor protein were increased, as determined by Western blotting. Immunohistostaining showed that during adenomyosis, PRL and its receptors are highly expressed in adenomyotic lesions. In cultured myometrial cells, protein expression of PRL and its receptors was increased during adenomyosis. Estradiol decreased PRLRs protein expression in nonadenomyotic stromal cells and in adenomyotic myometrial cells, and increased PRL secretion by adenomyotic myometrial cells. Moreover, PRL secretion was increased in untreated epithelial and stromal cells during adenomyosis. On the other hand, in stromal cells, PRLRs messenger RNA and protein expression was decreased, as determined by real-time PCR and Western blotting, respectively. Obtained results show that significant changes in PRL and PRLRs expression are observed in uterine tissue and cells during adenomyosis, which were also affected by E2. These data suggest involvement of PRL in adenomyosis development and the link between PRL and E2 actions during the dysfunction in cows.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- Adenomyosis: via openalex
- Adenomyosis in the bovine uterus: Correlation between frequency, age, and 17β-estradiol–progesterone equilibrium via openalex
- Animal model of uterine adenomyosis: Is prolactin a potent inducer of adenomyosis in mice? via openalex
- Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women via openalex
- Expression of pluripotency markers in the bovine uterus with adenomyosis via openalex
- Increased expression of prolactin receptor mRNA in adenomyotic uterus in mice via openalex
- Is adenomyosis a problem in reproduction and fertility? via openalex
- Oestrogen‐induced angiogenesis promotes adenomyosis by activating the <scp>S</scp>lug‐<scp>VEGF</scp> axis in endometrial epithelial cells via openalex
- Pathophysiology of adenomyosis via openalex
- Suppression of the development of uterine adenomyosis by danazol treatment in mice via openalex
- The Possible Role of Fluoxetine in Adenomyosis: An Animal Experiment with Clinical Correlations via openalex
- Uterine stem cells: What is the evidence? via openalex
- W2024398370 via openalex
- W2025485968 via openalex
- W2027462169 via openalex
- W2030601224 via openalex
- W2034021557 via openalex
- W2034026417 via openalex
- W2040424196 via openalex
- W2051315108 via openalex
- W2056105594 via openalex
- W2057122083 via openalex
- W2060904896 via openalex
- W2060991245 via openalex
- W2071212489 via openalex
- W2075957902 via openalex
- W2078371940 via openalex
- W2086649646 via openalex
- W2096176273 via openalex
- W2110070185 via openalex
- W2117916692 via openalex
- W2138605811 via openalex
- W2150801318 via openalex
- W2156742144 via openalex
- W2171692902 via openalex
- W2172283366 via openalex
- W2411734838 via openalex
- W6644431382 via openalex
- W1493535309 via openalex
- W1976187110 via openalex
- W1976720213 via openalex
- W1985118047 via openalex
- W1987250870 via openalex
- W1997142592 via openalex
- W2004016385 via openalex
- W2009081698 via openalex
- W2016594241 via openalex
- W2020470121 via openalex
- W2022846702 via openalex
Cited by (15)
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Medical Treatment of Adenomyosis 2022
- Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy 2022
- Unveiling the Pathogenesis of Adenomyosis through Animal Models 2022
- Current and Prospective Treatment of Adenomyosis 2021
- Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Serum prolactin and CA 125 levels in uterine adenomyosis 2020
- The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 2020
- Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study 2019
- Clinical evaluation of laparoscopic surgery combined with triptorelin acetate in patients with endometriosis and infertility 2018
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? 2018
Source provenance
- europepmc
- last seen: 2026-08-07T06:07:27.085738+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:54.390225+00:00
- unpaywall
- last seen: 2026-08-07T06:39:35.550527+00:00
License: CC0
· commercial use OK